PV Bulletin

MAXMAN Coffee may be harmful due to hidden drug ingredients

The FDA is advising against the purchase or use of MAXMAN Coffee due to undisclosed active ingredients that may pose health risks.

Primary source: form

PV Impact Brief

Urgency: HighConfidence: high

What changed

The FDA has advised the public not to purchase or use MAXMAN Coffee due to hidden drug ingredients discovered through laboratory analysis.

Why it matters

Undisclosed ingredients like sildenafil and tadalafil in MAXMAN Coffee pose serious health risks, especially for individuals with certain medical conditions or those taking medication that may interact with these substances.

Action needed

Enhanced monitoring for products with hidden drug ingredients is required, leading to increased need for rapid reporting and investigation of adverse events associated with similar products.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 2, 2026

Full briefing

Practical implication

Enhanced monitoring for products with hidden drug ingredients is required, leading to increased need for rapid reporting and investigation of adverse events associated with similar products.

The FDA has issued a warning about MAXMAN Coffee, confirming the presence of sildenafil and tadalafil, which are not listed on the product label. These ingredients, found in prescription medications for erectile dysfunction, can dangerously interact with certain medications and health conditions. Consumers are advised to refrain from using this product.

What changed: The FDA has advised the public not to purchase or use MAXMAN Coffee due to hidden drug ingredients discovered through laboratory analysis.

Why it matters: Undisclosed ingredients like sildenafil and tadalafil in MAXMAN Coffee pose serious health risks, especially for individuals with certain medical conditions or those taking medication that may interact with these substances.

Practical implication: Enhanced monitoring for products with hidden drug ingredients is required, leading to increased need for rapid reporting and investigation of adverse events associated with similar products.

View original source

  • Source: FDA - What's New Drugs RSS
  • Published at source: 2026-09-02T00:00:00.000Z
  • Discovered by monitor: 2026-09-02T21:39:57.538Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward